Is IP compliance mandatory for all foreign-invested enterprises in China?

Nearly 80% of foreign-invested enterprises (FIEs) operating in China face at least one IP compliance gap within their first 18 months, according to a 2024 survey by the China IP Office (CNIPA). The question “Is IP compliance mandatory for all FIEs in China?” has no simple yes-or-no answer — but the consequences of getting it wrong can shut down your operations.

China’s legal framework distinguishes sharply between mandatory IP filings that apply to every FIE and voluntary filings that become mandatory only when a specific transaction (licensing, assignment, joint venture contribution) occurs. This FAQ breaks down exactly what you must file, what you should file, and what happens if you don’t.

1. What Are the Three Mandatory IP Filing Categories for All FIEs?

For foreign-invested enterprises engaging in technology-related transactions, three categories of filings are legally compulsory. These are not optional — they are statutory requirements backed by Chinese law.

These three categories cover the vast majority of technology and brand-related transactions that FIEs regularly conclude in China: licensing patents to or from a Chinese entity, licensing trademarks to or from a Chinese entity, and importing technology under a contract that transfers or licenses proprietary technical knowledge.

2. Technology Import Contract Registration — The 60-Day MOFCOM Deadline

The Technology Import and Export Regulations of the People’s Republic of China (技术进出口管理条例 jishu jinchukou guanli tiaoli) require that any contract under which technology is transferred from a foreign party to a Chinese party must be registered with the Ministry of Commerce (MOFCOM 商务部 shangwubu) or its local counterpart within 60 days of the contract signing date.

This obligation is broader than many FIEs realise. It covers not only outright technology transfer agreements but also:

• Software licensing agreements where the software will be used by a Chinese subsidiary
• Technical know-how agreements accompanying equipment supply
• Engineering and technical service contracts that involve proprietary methods
• Franchise agreements that disclose trade secrets or proprietary business systems
• Joint venture technology contribution agreements

Scope of “Technology Import”

Article 2 of the Regulations defines “technology import” broadly as any technology transferred from outside China to inside China through trade, investment, or economic cooperation. The regulation specifically covers patents, proprietary technology, and technical services. Even if the technology is already known in China or is being transferred between related parties (e.g., from a foreign parent to its Chinese wholly-owned subsidiary), the registration requirement applies.

The Registration Process

1. Prepare documentation: Contract copy (Chinese version or bilingual), technology description, identity documents of both parties, and a registration application form.
2. Submit to MOFCOM: Filing is done through the MOFCOM online system or in person at the local commission of commerce where the Chinese recipient is registered.
3. Receive registration certificate: MOFCOM issues a “Technology Import Contract Registration Certificate” (技术进口合同登记证书 jishu jinkou hetong dengji zhengshu), which is critical for subsequent tax and customs procedures.
4. Tax filing: The registration certificate is required to process withholding tax on royalty payments and to qualify for reduced withholding tax rates under applicable tax treaties.

Consequences of Non-Compliance

Failing to register a technology import contract within 60 days renders the contract unenforceable in Chinese courts. This means that even if a Chinese licensee stops paying royalties, the foreign licensor cannot sue to enforce payment. Additionally, remittances of royalties abroad through Chinese banks will be blocked because banks require the registration certificate for cross-border payments exceeding certain thresholds.

Beyond unenforceability, Article 17 of the Regulations empowers MOFCOM to impose administrative penalties, including fines. In practice, late registration (as opposed to no registration) is often accepted with a late fee, but contracts that are completely unregistered for extended periods risk formal sanctions.

3. Patent License Contract Filing Under Patent Law Article 34

Article 34 of the Patent Law (专利法 zhuanlifa) requires that any patent licensing contract between parties with at least one Chinese party must be filed with CNIPA within three months of execution. The filing is a prerequisite for the license to be effective against third parties.

Key points to understand:

• It applies to all patent types: Invention patents (发明专利 faming zhuanli), utility model patents (实用新型 shiyong xinxing), and design patents (外观设计 waiguan sheji).
• Both exclusive and non-exclusive licenses must be filed. There is no de minimis exception for short-term or low-value licenses.
• Cross-border licenses are covered: A patent license from a foreign patent holder to a Chinese FIE subsidiary requires filing just as a license between two Chinese entities does.
• Sub-licenses must also be filed: If the Chinese licensee sub-licenses the patent to another Chinese entity, that sub-license contract must also be filed.

Why Filing Matters

The filing serves a public notice function. Until a patent license is filed with CNIPA, it is not opposable to third parties. If the patent is later transferred to a new owner, or if a third party obtains a conflicting license and files first, an unfiled license may lose priority. This is analogous to the recording system for real property interests — filing establishes priority.

Furthermore, CNIPA’s public patent license registry is the authoritative source for determining who has rights to practice a patent in China. Without a filing, the licensee cannot prove its rights to customs authorities (relevant for import/export of patented goods) or to Chinese courts in infringement proceedings.

4. Trademark License Contract Filing Under Trademark Law Article 43

Article 43 of the Trademark Law (商标法 shangbiaofa) imposes a parallel obligation for trademark licensing. Any trademark license contract must be filed with CNIPA within three months. Like patent licenses, an unfiled trademark license is not effective against third parties.

This requirement is particularly important for FIEs that license global brands to their Chinese subsidiaries or to Chinese distributors. Common scenarios include:

• A foreign brand owner licensing its Chinese-registered trademark to its WFOE (wholly foreign-owned enterprise) for local manufacturing
• A Chinese distributor licensed to use the FIE’s trademark in retail operations
• A joint venture using the foreign partner’s trademark under a license agreement
• Franchise operations where the trademark is a core component of the franchise system

Trademark Squatting — A Real Threat

One of the most compelling reasons to file trademark licenses promptly — and to register trademarks in China before licensing them — is the widespread problem of trademark squatting (商标抢注 shangbiao qiangzhu). China operates on a “first-to-file” system, meaning the first party to register a trademark in China owns it, regardless of prior use in other jurisdictions.

FIEs that license trademarks in China without first ensuring the marks are properly registered in China expose themselves to serious risk. A squatter who registers the mark can block the FIE’s license filing, demand exorbitant buyout fees, or even sue the FIE’s Chinese licensee for infringement. Annual cases of trademark squatting affecting foreign companies in China number in the thousands, with resolution costs frequently exceeding RMB 500,000 per case.

5. What About Joint Ventures (JV) and Regulated Industries?

Joint ventures (合资企业 hezi qiye) and regulated industries face additional IP compliance layers beyond the three core filings.

Joint Ventures and IP Valuation

When IP is contributed as capital to a Chinese joint venture, the transaction attracts two additional requirements:

• Company Law Article 48 (公司法第48条 gongsifa di 48 tiao): Non-monetary capital contributions, including IP, must be assessed by a qualified appraisal institution and cannot be overvalued or undervalued. The appraised value is recorded in the JV’s registered capital structure and must be verified by a Chinese CPA firm.
• Technology import registration: If the IP originates from outside China (almost always the case for foreign JV partners), the contribution is treated as a technology import and must be registered with MOFCOM within 60 days of the JV contract signing.
• Patent and/or trademark license filing: Even within a JV structure, if the IP is licensed rather than assigned, separate patent and trademark filings are required.

Failure to properly appraise and register IP contributions can invalidate the capital contribution entirely, leading to shareholder disputes and potential de-registration of the JV.

Regulated Industries

Certain industries in China are subject to additional IP-related compliance obligations:

Pharma Patent Linkage — A Special Case

China’s pharmaceutical patent linkage system (药品专利链接 yao pin zhuanli lianjie), established under the 2021 Patent Law amendments and implemented through the 2022 Detailed Rules, creates a unique compliance burden for pharma FIEs. Under this system:

1. Patent holders must register their relevant patents on the China Drug Master File (CDMF) patent list for each approved drug
2. Generic applicants must declare the status of each listed patent (similar to the US Hatch-Waxman framework)
3. A 9-month stay of marketing authorisation applies if the patent holder files a timely infringement action
4. Failure to register a patent on the CDMF list within the prescribed window may result in the patent being ineligible for linkage protection

For FIE pharmaceutical companies, the patent linkage system makes IP compliance a prerequisite for market exclusivity. A missed filing can open the door to generic competition years earlier than the patent term would otherwise allow.

6. What Are the Penalties for Non-Compliance?

The penalties for failing to meet mandatory IP compliance obligations in China range from administrative inconvenience to complete loss of legal enforceability. Here is a summary of the most significant consequences:

Contract Unenforceability

This is the most serious penalty. Under both the Technology Import/Export Regulations and the Judicial Interpretation on Patent Licensing Disputes, an unregistered technology import contract or patent license is unenforceable in Chinese courts. This means:

• No royalty collection: You cannot sue a non-paying licensee to recover unpaid royalties.
• No injunction: You cannot obtain a court order to stop a licensee from using the technology after the license term expires if the license was never filed.
• No damages for breach: You cannot recover damages for breach of an unfiled license agreement.

Administrative Fines

Article 17 of the Technology Import/Export Regulations authorises MOFCOM to impose fines of up to RMB 30,000 for failure to register a technology import contract. While this amount is relatively modest compared to the commercial value at stake, the fine is accompanied by an order to register the contract — and until registration is complete, the contract remains unenforceable.

Cross-Border Payment Blockage

Chinese banks and the State Administration of Foreign Exchange (SAFE 国家外汇管理局 guojia waihui guanliju) require the MOFCOM registration certificate before processing outbound royalty or technology fee payments exceeding USD 50,000 (or their equivalent). Without the certificate, the FIE simply cannot pay the foreign licensor or technology provider. This creates a practical impossibility for the transaction even if the parties are willing to accept the legal risk.

Tax Consequences

Under China’s tax treaty network, royalty withholding tax rates can be as low as 5%–10% for treaty-eligible recipients. However, the reduced rate is conditional on the taxpayer holding a valid MOFCOM technology import registration certificate. Without it, the default withholding rate of 20% (or the domestic rate of 10% for non-treaty jurisdictions) applies — doubling or quadrupling the tax cost of the license.

Priority Loss

For patent and trademark licenses, the failure to file with CNIPA means the license loses priority against third parties. If the patent or trademark is transferred to a new owner, or if a third party records a conflicting license first, the unfiled license becomes subordinate. In practical terms, this means a later-filed license held by a competitor could take priority over the FIE’s earlier-executed but unfiled license.

7. Which Filings Are Voluntary But Strongly Recommended?

Beyond the three mandatory categories, several IP filings are legally voluntary but commercially essential. Experienced FIEs treat them as effectively mandatory because the cost of omission is so high.

Trademark Registration

While China does not require trademark registration, the “first-to-file” system means that an unregistered mark has virtually no protection against third-party use. An FIE that uses an unregistered trademark in China — even a globally famous brand — cannot prevent a squatter from registering it. Under Article 32 of the Trademark Law, prior use can be asserted, but the evidentiary burden is heavy and success is uncertain.

Recommendation: Register all core brands in China before any licensing, manufacturing, or distribution begins. First-to-file means every day of delay is a day a squatter can act.

Patent Filing in China

Patents are territorial — a US patent, European patent, or Japanese patent confers no protection in China. To exclude others from making, using, or selling the patented invention in China, the FIE must obtain a Chinese patent. The Paris Convention provides a 12-month priority window (6 months for design patents) from the first filing date in another member country, but the Chinese patent application must be filed within that window.

Recommendation: For any invention with commercial significance in China, file a Chinese patent application within the Paris Convention priority window. Consider filing simultaneously with the home-country application for critical technologies.

Trade Secret Protection Measures

China’s Anti-Unfair Competition Law (反不正当竞争法 fan bu zhengdang jingzheng fa) protects trade secrets, but enforcement requires the rights-holder to demonstrate that reasonable protection measures were in place. For FIEs, this means implementing physical, technical, and contractual safeguards:

1. NDAs with all employees and business partners accessing confidential technical information
2. IT access controls, data encryption, and audit trails for trade secret databases
3. Physical access restrictions to R&D and production facilities
4. Clear trade secret identification and marking procedures
5. Exit interview protocols that confirm the return of confidential materials

Without such measures, even a proven misappropriation of trade secrets may not lead to a remedy — the court may find that the rights-holder failed to exercise reasonable care and therefore cannot claim trade secret protection.

8. How Do Company Law Article 48 and IP Valuation Fit In?

Company Law Article 48 (公司法第48条 gongsifa di 48 tiao) is directly relevant to FIEs that contribute IP to a Chinese entity — a common structure in both joint ventures and capital increases in WFOEs.

The Article requires that any non-monetary capital contribution (including patents, trademarks, copyrights, and trade secrets) be:

• Appraised by a qualified valuation institution registered with the Ministry of Finance
• Verified by a Chinese CPA firm as part of the capital verification process
• Recorded at the appraised value in the company’s registered capital and business license

Overvaluation of contributed IP is a specific risk. If the contributed IP is later determined to have been overvalued at the time of contribution, the contributing shareholder is liable to make up the shortfall in cash. Additionally, the shareholder may face administrative penalties for false capital contribution.

For FIEs, this means:

• IP contributed to a JV or WFOE as registered capital must be professionally appraised in accordance with Chinese valuation standards (which differ from IFRS or US GAAP standards in material respects)
• The appraisal must be completed before the capital contribution is recorded — retrospective appraisals are generally not accepted
• The IP must be transferred (assigned) to the Chinese entity, not merely licensed, to qualify as a capital contribution — and that transfer triggers patent and trademark assignment filings
• Technology import registration with MOFCOM applies if the IP originates from outside China, which it almost always does for foreign-invested enterprises

9. Practical Compliance Checklist for FIEs

Based on the laws and requirements outlined above, every FIE operating in China should run through this compliance checklist annually, quarterly for the first year of establishment:

10. Common Misconceptions About IP Compliance in China

After years of advising FIEs on Chinese IP compliance, we encounter several recurring misconceptions that lead to costly mistakes:

“My Chinese WFOE is my own company — I don’t need to register technology transfer to myself.” This is incorrect. Chinese law treats a foreign parent and its Chinese subsidiary as separate legal persons for technology import purposes. Every cross-border technology license, even between related parties, requires MOFCOM registration.

“Unregistered IP is still protected by common law rights.” China does not recognise common law trademark rights. Without Chinese registration, a trademark has no statutory protection against infringement or squatting. Prior use can be argued under Article 32 of the Trademark Law, but it is a defence, not a property right.

“The RMB 30,000 fine is the only penalty, so it’s cheaper to skip registration.” The RMB 30,000 administrative fine is negligible compared to the commercial consequences: contract unenforceability, blocked cross-border payments, doubled withholding tax, and loss of IP priority. The fine is the least of your worries.

“Patent linkage only matters for innovator drugs, not generics or devices.” While the patent linkage system was designed primarily for innovative pharmaceuticals, its scope covers all chemical drugs, biologics, and traditional Chinese medicines (TCMs) that reference a listed patent. Medical device patents are not yet subject to linkage, but NMPA is actively considering expansion.

“Our IP is covered by international treaties, so we don’t need local registration.” International treaties such as the Paris Convention and the Patent Cooperation Treaty (PCT) provide filing priority windows and procedural facilitation, but they do not grant substantive patent or trademark rights in China. A Chinese patent or trademark registration is required to obtain and enforce rights.

Where to Go From Here

Based on what you just read:

• [guide: SLUG-TO-BE-FILLED]
• [comparison: SLUG-TO-BE-FILLED]
• [tool: SLUG-TO-BE-FILLED]

— China Gateway 360 —
Remote China market entry support, built around execution.

Official Sources

• China National Intellectual Property Administration: Trademark Law
• China National Intellectual Property Administration: official service portal
• World Intellectual Property Organization: China legal and treaty resources